Pharmacologic Rationale for Trimetazidine in the Treatment of Ischemic Heart Disease
- 期刊名称American Journal of Cardiovascular Drugs
- 作者Professor Gary D. Lopaschuk
- 卷第3卷
- 印刷ISSN1175-3277
- 电子ISSN1179-187X
- 文件大小110.65KB
- 发表时间2003-12
- DOI10.2165/00129784-200303001-00003
- 页码21-26
Desmethyl bosentan displays a similar in vitro interaction profile as bosentanWeiss, Johanna; Baumann, Sybille; Theile, Dirk; Haefeli, Walter Emil · Pulmonary Pharmacology & Therapeutics · 2015
COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL COMPARED WITH BOSENTAN ALONE IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSIONAl-Sharif, Hassan; Bshouty, Zoheir · Chest · 2006
Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reportsTomoki Ito,Yoshio Ozaki,Yonsu Son,Tohru Nishizawa… · Journal of Medical Case Reports · 2014
Consecutive use of sildenafil and bosentan for the treatment of pulmonary arterial hypertension associated with collagen vascular disease: sildenafil as reliever and bosentan as controllerKamata, Y.; Iwamoto, M.; Minota, S. · Lupus · 2007
Comparison of the Inhibitory Effect of Ketoconazole, Voriconazole, Fluconazole, and Itraconazole on the Pharmacokinetics of Bosentan and Its Corresponding Active Metabolite Hydroxy Bosentan in RatsChen, Mengchun; Zhang, Xufei; Chen, Yijie; Sun, Wei; Wang, Zhe; Huang, Chengke; Hu, Guoxin; Chen, Ruijie · Xenobiotica · 2019
Delayed hypersensitivity to bosentanA. Romano; A. Giovannetti; C. Caruso; E. Rosato; M. Pierdominici; F. Salsano · 2009
La découverte du bosentanM. Clozel · 2007
Bosentan in mild pulmonary hypertensionGeorgios Giannakoulas; Konstantinos Dimopoulos; Michael A Gatzoulis · 2008
Bosentan: profile reportLewis J. Rubin,Martin R. Wilkins,Gideon Paul · Drugs & Therapy Perspectives · 2003
Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertensionGideon A. Paul; J Simon R. Gibbs; Alan R. Boobis; Allifia Abbas; Martin R. Wilkins · 2005
Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertensionVahitha B. Abdul-Salam; Gideon A. Paul; J. Omar Ali; Simon R. Gibbs; Dinah Rahman; Graham W. Taylor; Martin R. Wilkins; Robert J. Edwards · 2006
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) StudyWilkins, Martin R.; Paul, Gideon A.; Strange, Julian W.; Tunariu, Nina; Gin-Sing, Wendy; Banya, Winston A.; Westwood, Mark A.; Stefanidis, Alexander; Ng, Leong L.; Pennell, Dudley J.; Mohiaddin, Raad H.; Nihoyannopoulos, Petros; Gibbs, J. Simon R. · American Journal of Respiratory and Critical Care Medicine · 2005
Controlled-Release CarvedilolCarter, Natalie J; Keating, Gillian M · American Journal of Cardiovascular Drugs · 2008
BosentanOldfield, Vicki; Lyseng-Williamson, Katherine A · American Journal of Cardiovascular Drugs · 2006
BosentanPrakash, Amitabh; Perry, Caroline M. · American Journal of Cardiovascular Drugs · 2002
CilostazolChapman, Therese M; Goa, Karen L · American Journal of Cardiovascular Drugs · 2003
Fully Biodegradable Coronary StentsRamcharitar, Steve; Serruys, Patrick W · American Journal of Cardiovascular Drugs · 2008
Cocaine CardiotoxicityPhillips, Katharine; Luk, Adriana; Soor, Gursharan S.; Abraham, Jonathan R.; Leong, Shaun; Butany, Jagdish · American Journal of Cardiovascular Drugs · 2009
ValsartanWellington, Keri; Goa, Karen L. · American Journal of Cardiovascular Drugs · 2002
Prise en chargeBauters, Christophe · American Journal of Cardiovascular Drugs · 2007